17 March 2022 - ZYNRELEF is the first and only extended-release local anaesthetic approved by Health Canada.
Heron Therapeutics today announced that Health Canada has issued a Notice of Compliance to commercialise Zynrelef (bupivacaine and meloxicam extended-release solution) for instillation into the surgical wound for postoperative analgesia after bunionectomy, open inguinal herniorrhaphy, and total knee arthroplasty surgical procedures.